Mode
Text Size
Log in / Sign up

General obesity, central obesity, and high triglycerides increase risk of precancerous polyps in colorectal cancer surveillanceMetabolic health matters for colon cancer risk in high-risk surveillance patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider metabolic factors when recommending surveillance colonoscopy intervals for colorectal cancer risk.

This is a meta-analysis of 24 observational studies examining metabolic risk factors for precancerous polyps in individuals at above-average risk for colorectal cancer undergoing surveillance colonoscopy. The analysis found that general obesity (pooled odds ratio [POR] 1.31, 95% CI 1.09-1.57), central obesity (POR 1.31, 95% CI 1.16-1.49), hypertension (POR 1.22, 95% CI 1.02-1.44), high triglycerides (POR 1.39, 95% CI 1.06-1.83), and metabolic syndrome (pooled hazard ratio [PHR] 1.24, 95% CI 1.01-1.51) were significant risk factors for any precancerous polyp. For advanced precancerous polyps, general obesity showed a strong association (PHR 3.04, 95% CI 2.01-4.60), while diabetes was not significantly associated (PHR 1.07, 95% CI 0.72-1.57). The authors note inconsistent associations for diabetes and nonalcoholic fatty liver disease with overall precancerous polyps. Heterogeneity was reported (I² up to 67%). The source is a meta-analysis of observational studies, so effect estimates reflect associations, not causation. Practice relevance suggests metabolic factors should be considered when recommending surveillance colonoscopy intervals, but the evidence is limited by observational design and heterogeneity.

People at above-average risk for colorectal cancer often get regular surveillance colonoscopies to catch problems early. But what happens between those appointments? A new analysis of 24 studies looks at how everyday metabolic factors affect polyp growth. The findings show that general obesity, central obesity, high triglycerides, hypertension, metabolic syndrome, and diabetes are all significant risk factors for developing any precancerous polyp. These conditions are common and often go unnoticed until they become serious health issues. The data suggests that having these metabolic problems makes it more likely for a person to develop a polyp during their surveillance period. This is important because polyps can turn into cancer if left untreated. The study also found that general obesity is strongly linked to advanced precancerous polyps, which are more dangerous than simple growths. However, the link between diabetes and overall polyp development was not consistent across all the studies included in the review. This inconsistency means we cannot say for sure that diabetes causes polyps in every case. The researchers pooled data from many sources to get a clearer picture, but they noted that the results varied in some ways. They also pointed out that these studies show associations, not direct causes. This means having a metabolic condition increases risk, but it does not guarantee that a polyp will form. Understanding these links helps doctors think more carefully about how often to check patients. If a person has multiple metabolic issues, their doctor might consider recommending more frequent surveillance colonoscopies to catch any changes early. This approach could help prevent cancer before it starts by finding and removing polyps while they are still small and harmless.

What this means for you:
Metabolic factors like obesity and diabetes increase the risk of precancerous polyps in high-risk patients.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
INTRODUCTION: While the association between metabolic factors and risk of colorectal cancer (CRC) in the general population is well established, their effect on precancerous polyps among individuals undergoing surveillance colonoscopy is not well understood. Additionally, most guidelines do not consider metabolic factors when determining surveillance colonoscopy intervals. This systematic review and meta-analysis summarizes current evidence for this association in individuals at above-average risk for CRC. METHODS: Relevant studies published from 2010 through 2023 were identified using seven databases. Two independent reviewers performed abstract and full-text screening and quality assessment. Effect estimates were reported using a pooled odds ratio (POR) or pooled hazard ratio (PHR) based on the primary studies measurement with 95% confidence intervals and heterogeneity was reported as I. RESULTS: 15,486 studies were screened, with 24 meeting the inclusion criteria. General obesity (POR = 1.31, 95% CI 1.09-1.57, I = 67%), central obesity (POR = 1.31, 95% CI 1.16-1.49, I = 0%), hypertension (POR = 1.22, 95% CI 1.02-1.44, I = 57%), high triglyceride (POR = 1.39, 95% CI 1.06-1.83, I = 0%), and metabolic syndrome (PHR = 1.24, 95% CI 1.01-1.51, I = 24%) were significant risk factors for the development of any precancerous polyp. The association between diabetes and nonalcoholic fatty liver disease and overall precancerous polyps was inconsistent. General obesity (PHR = 3.04, 95% CI 2.01-4.60, I = 0%) but not diabetes (PHR = 1.07, 95% CI 0.72-1.57, I = 0%) was significantly associated with the risk of advanced precancerous polyps. CONCLUSION: Metabolic factors should be considered when recommending surveillance colonoscopy intervals, which in most guidelines are mainly determined based on the findings at colonoscopy, the significance of family history of CRC and genetic predispositions.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.